Stanley Xu to Disease Progression
This is a "connection" page, showing publications Stanley Xu has written about Disease Progression.
Connection Strength
1.308
-
De-escalating low-dose rituximab up to every 24-month infusions and the risk of disease activity in people with relapsing multiple sclerosis who were stable the first year on therapy. Mult Scler. 2026 Apr; 32(4):409-420.
Score: 0.879
-
Comparative Effectiveness of Rituximab Dosed Every 6 and 12 Months in Relapsing Multiple Sclerosis. Neurology. 2026 Jan 27; 106(2):e214473.
Score: 0.216
-
Neighborhood Deprivation and Crime on Asthma Exacerbations and Utilization in Mild Adult Asthma. J Allergy Clin Immunol Pract. 2024 Nov; 12(11):2966-2974.e11.
Score: 0.197
-
A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children. Pediatrics. 2008 Mar; 121(3):e506-12.
Score: 0.016